Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1024 | Thyroid | ECE2022

TSHR promoter methylation level changes as a prognostic blood-based biomarker in follicular thyroid carcinoma

Kazokaite Mintaute , Zukauskaite Kristina , Klimaitė Raimonda , Kondrotienė Aistė , Daukšienė Dalia , Zilaitiene Birute , Sabaliauskaite Rasa , Dauksa Albertas

Introduction: Papillary thyroid carcinoma (PTC) is the most common type of differentiated thyroid cancer, accounting for about 80% of all cases of thyroid cancer. Generally, PTC is an indolent disease and shows a good prognosis in most patients. However, up to 30% of patients have local tumor renewal or systemic spread. It is crucial to identify patients with a high risk of disease progression. DNA methylation biomarkers may provide clinically valuable information and improve ...

ea0090ep965 | Thyroid | ECE2023

The role of PTEN methylation level changes in papillary thyroid carcinoma diagnosis and prognosis

Kazlauskiene Mintaute , Zukauskaite Kristina , Klimaitė Raimonda , Kondrotienė Aistė , Daukšienė Dalia , Zilaitiene Birute , Sabaliauskaite Rasa , Dauksa Albertas

Introduction: Papillary thyroid cancer (PTC) is the most common type of thyroid cancer (85%–90%). Today Fine needle aspiration biopsy (FNAB) is the diagnostic tool for the evaluation of thyroid nodules because of its accuracy and cost-effectiveness, but FNAB also has limitations, as it is quite challenging to take a biopsy from a small thyroid nodule moreover FNAB diagnosis is doubtful in up to 20% of cases. Therefore, non-invasive biomarkers of PTC are needed.<p clas...